Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Aytu Biopharma stock | $5.08
Learn how to easily invest in Aytu Biopharma stock.
Aytu Biopharma, Inc is a biotechnology business based in the US. Aytu Biopharma shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Aytu Biopharma employs 75 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Aytu Biopharma
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AYTU – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Aytu Biopharma stock price (NASDAQ: AYTU)Use our graph to track the performance of AYTU stocks over time.
Aytu Biopharma shares at a glance
|Latest market close||$5.08|
|52-week range||$3.86 - $14.50|
|50-day moving average||$4.86|
|200-day moving average||$6.58|
|Wall St. target price||$19.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.48|
Buy Aytu Biopharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aytu Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aytu Biopharma price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-0.78%|
|3 months (2021-04-30)||-23.26%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Aytu Biopharma financials
|Revenue TTM||$57 million|
|Gross profit TTM||$20.1 million|
|Return on assets TTM||-8.77%|
|Return on equity TTM||-37.09%|
|Market capitalisation||$102.9 million|
TTM: trailing 12 months
Shorting Aytu Biopharma shares
There are currently 2.0 million Aytu Biopharma shares held short by investors – that's known as Aytu Biopharma's "short interest". This figure is 21.9% up from 1.6 million last month.
There are a few different ways that this level of interest in shorting Aytu Biopharma shares can be evaluated.
Aytu Biopharma's "short interest ratio" (SIR)
Aytu Biopharma's "short interest ratio" (SIR) is the quantity of Aytu Biopharma shares currently shorted divided by the average quantity of Aytu Biopharma shares traded daily (recently around 1.5 million). Aytu Biopharma's SIR currently stands at 1.32. In other words for every 100,000 Aytu Biopharma shares traded daily on the market, roughly 1320 shares are currently held short.
However Aytu Biopharma's short interest can also be evaluated against the total number of Aytu Biopharma shares, or, against the total number of tradable Aytu Biopharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aytu Biopharma's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Aytu Biopharma shares in existence, roughly 80 shares are currently held short) or 0.0895% of the tradable shares (for every 100,000 tradable Aytu Biopharma shares, roughly 90 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aytu Biopharma.
Find out more about how you can short Aytu Biopharma stock.
Aytu Biopharma share dividends
We're not expecting Aytu Biopharma to pay a dividend over the next 12 months.
Have Aytu Biopharma's shares ever split?
Aytu Biopharma's shares were split on a 1:10 basis on 8 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aytu Biopharma shares which in turn could have impacted Aytu Biopharma's share price.
Aytu Biopharma share price volatility
Over the last 12 months, Aytu Biopharma's shares have ranged in value from as little as $3.86 up to $14.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu Biopharma's is -0.2824. This would suggest that Aytu Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu Biopharma has bucked the trend.
Aytu Biopharma overview
Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021.
Stocks similar to Aytu Biopharma
Aytu Biopharma in the news
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with Coronavirus
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Frequently asked questionsWhat percentage of Aytu Biopharma is owned by insiders or institutions?
Currently 7.276% of Aytu Biopharma shares are held by insiders and 28.413% by institutions. How many people work for Aytu Biopharma?
Latest data suggests 75 work at Aytu Biopharma. When does the fiscal year end for Aytu Biopharma?
Aytu Biopharma's fiscal year ends in June. Where is Aytu Biopharma based?
Aytu Biopharma's address is: 373 Inverness Parkway, Englewood, CO, United States, 80112 What is Aytu Biopharma's ISIN number?
Aytu Biopharma's international securities identification number is: US0547547002 What is Aytu Biopharma's CUSIP number?
Aytu Biopharma's Committee on Uniform Securities Identification Procedures number is: 054754106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert